26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
Today, data is a valuable asset for all organisations, not just ‘tech’ companies. Regardless of se...
Read More >
Although there have only been a handful of confirmed cases of the 2019 Novel Coronavirus (2019-nCoV ...
Read More >
Just before Christmas, the National Labor Relations Board (“NLRB”) evaluated two dress code polici...
Read More >
On September 18, 2019, California Governor Gavin Newsom signed Assembly Bill (“AB”) 5, thereby cod...
Read More >
We have reminded you before of the importance of obtaining authorization from the Federal Communicat...
Read More >
This presentation provides a general overview of market changes that have occurred in the upstream o...
Read More >